Deep learning-based quantitative histopathology of endoscopic biopsies in Crohn’s disease: a retrospective cross-sectional validation study - Summary - MDSpire
Advertisement
Deep learning-based quantitative histopathology of endoscopic biopsies in Crohn’s disease: a retrospective cross-sectional validation study
To develop and clinically validate a deep learning-based framework for quantitative assessment of endoscopic biopsies in Crohn's disease, addressing the limitations of conventional histologic assessment.
Key Findings:
AI models showed robust internal performance with Dice coefficients and AUC values exceeding 0.95.
AI-derived crypt abscess and cryptitis ratios demonstrated good concordance with pathologist assessments, indicating potential for clinical application.
Weak agreement was noted for submucosal plasma cell density (CCC = 0.376), which may limit its clinical utility.
AI-derived features showed weak to moderate associations with clinical or endoscopic activity, suggesting further investigation is needed.
Greater submucosal inflammatory infiltration was observed in CD biopsies compared to non-CD inflammatory colitis, highlighting the distinct pathology of CD.
Interpretation:
The AI-based framework provides objective and reproducible tissue-level quantification of Crohn's disease histopathology, complementing routine pathologic assessment.
Limitations:
AI over-detection in submucosal regions with negative or low manual scores, which may lead to misinterpretation of results.
Associations between AI-derived features and clinical indicators were generally weak to moderate, indicating the need for cautious interpretation.
Conclusion:
The framework offers a practical pathologist-supervised approach for standardizing histologic evaluation in Crohn's disease, with potential for future enhancements to improve accuracy.
The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production